Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Wang

MA21.09 Differential Gene Expression in Tumor and Normal Tissue Reveals New Insights in the Biology of Non-Small Cell Lung Carcinoma.

Journal of Thoracic Oncology

English

P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

Journal of Thoracic Oncology

English

Correction: Toosendanin Demonstrates Promising Antitumor Efficacy in Osteosarcoma by Targeting STAT3

English

P1.09-08 Integrating NGS Information for Staging Multiple Lung Adenocarcinoma: A McGill University Health Centre Retrospective Study

Journal of Thoracic Oncology

English

P2.03-041 the Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients With T790M Mutation

Journal of Thoracic Oncology

English

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC PTS With Oligometastatic or Oligoprogressive Liver Metastases

Journal of Thoracic Oncology

English

P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC and Treating Drug-Resistant Lung Cancer Mice

Journal of Thoracic Oncology

English

P1.03-06 Molecular Landscape of FGFR1 Point Mutations in Chinese Non-Small-Cell Lung Cancer Patients: A Retrospective Study

Journal of Thoracic Oncology

English

OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.

Journal of Thoracic Oncology

English

Programme and Policy Options for Preventing Obesity in China

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Wang

MA21.09 Differential Gene Expression in Tumor and Normal Tissue Reveals New Insights in the Biology of Non-Small Cell Lung Carcinoma.

P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

Correction: Toosendanin Demonstrates Promising Antitumor Efficacy in Osteosarcoma by Targeting STAT3

P1.09-08 Integrating NGS Information for Staging Multiple Lung Adenocarcinoma: A McGill University Health Centre Retrospective Study

P2.03-041 the Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients With T790M Mutation

OA07.03 Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC PTS With Oligometastatic or Oligoprogressive Liver Metastases

P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC and Treating Drug-Resistant Lung Cancer Mice

P1.03-06 Molecular Landscape of FGFR1 Point Mutations in Chinese Non-Small-Cell Lung Cancer Patients: A Retrospective Study

OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.

Programme and Policy Options for Preventing Obesity in China